Mert Üğe

Dr. Mert Üğe


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Journal of Medical Biochemistry
Verified
Journal Article
Open access
MÜMert Üğe
Mert Üğe
SASaliha Aksun
Saliha Aksun
Background: Laboratories have a responsibility to produce accurate and reliable results to ensure patient safety and meet quality standards. Within the Six SIGMA quality management framework, various approaches may emerge depending on the total allowable error (TAE) limits defined by different standards. This study aimed to compare analyte SIGMA levels using CLIA 1988 and CLIA 2024 criteria, determine appropriate quality control procedures based on Westgard multirules, and identify potential sources of error using the Quality Goal Index. Methods: SIGMA values for 17 biochemical analytes were calculated based on internal and external quality control data using the formula (TEa - bias)/CV The Quality Goal Index (QGI) was determined using the formula bias/(1.5xCV). All analytes were evaluated at the Karabuk Public Health Laboratory between November 2024 and March 2025. Results: Amylase (Levels 1 and 2), total bilirubin (Level 1), high-density lipoprotein cholesterol (Levels 1 and 2), creatine kinase (Levels 1 and 2), and lactate dehydrogenase (Levels 1 and 2) demonstrated world-class SIGMA performance according to both CLIA 1988 and CLIA 2024 standards. However, a decline in SIGMA values was observed when calculated using the more stringent CLIA 2024 limits. Conclusions: The comparison of CLIA 1988 and CLIA 2024 standards demonstrated that stricter TEa limits can significantly impact the performance of SIGMA. While some analytes maintained world-class performance, others exhibited a notable decline, necessitating enhanced quality control measures. These findings emphasise the need for laboratories to periodically reassess test performance in light of evolving regulatory standards to ensure continued analytical reliability and patient safety.

29 March 2022 in Türk Kadın Sağlığı ve Neonatoloji Dergisi
Verified
Journal Article
Closed access
PDF file
MÜMert Üğe
Mert Üğe
LDLeyla Demi̇r
Leyla Demi̇r
SASaliha Aksun
Saliha Aksun
Amaç: Bu çalışmada, laboratuvarımızda yapılan prenatal tarama testlerinin güncel medyan değerlerinin hesaplanması ve risk hesaplamada kullandığımız paket programdaki medyan değerler ile karşılaştırılması hedeflenmiştir. Gereç ve Yöntem: Mayıs 2019-Mayıs 2020 tarihleri arasında İzmir ili ve çevresinden hastanemize yapılan başvurular sonucu 3264 birinci trimester tarama testi, 954 ikinci trimester tarama testi retrospektif olarak incelendi. Tüm parametreler İzmir Katip Çelebi Üniversitesi Atatürk Eğitim Araştırma Hastanesi Tıbbi Biyokimya Laboratuvarı’nda maternal serumdan çalışıldı. Elde edilen verilerin gebelik haftalarına göre güncel medyan değerleri ve medyan katları hesaplandı. Prisca paket programındaki medyan değerler ile istatistiksel olarak karşılaştırıldı. Bulgular: Güncel medyan değerlerinin; tüm haftalarda birinci trimester tarama testinde kullanılan free β-hCG için düşük, PAPP-A için yüksek olduğu, ikinci trimester tarama testinde kullanılan total β-hCG için 19. hafta dışında düşük olduğu görüldü (p

1 September 2025 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
LÜLeyla Abalı Üğe
Leyla Abalı Üğe
YÜYusuf Üzüm
Yusuf Üzüm
MÜMert Üğe
Mert Üğe
ZSZeki Soypacaci
Zeki Soypacaci
Purpose: We aimed to determine the predisposing factors for contrast-associated acute kidney injury (CA-AKI) among patients exposed to contrast media during emergency department visits and follow-ups in internal medicine, and to evaluate subsequent outcomes such as mortality and intensive care unit (ICU) admission. Patients and Methods: A total of 1483 patients who presented to the internal medicine clinic from the emergency department or outpatient clinic and underwent contrast-enhanced computed tomography (CT) were retrospectively analyzed. A total of 382 cases with kidney function tests available for the study before contrast exposure and at 24, 72, and 120 hours after exposure were included in the study. An increase in serum creatinine by 25% or more from the baseline or an absolute increase of 0.5 mg/dl (44.20 μmol/L) or more after one hour was considered as contrast nephropathy. Results: Contrast-associated acute kidney injury was observed in 17% of the study population, with the majority of cases emerging within the initial 24-hour period following contrast exposure. In 54% of these patients, contrast media had been administered in the internal medicine department. Among them, 13.9% subsequently required admission to the intensive care unit (ICU). Furthermore, individuals with a history of hypertension were found to have a 2.31-fold increased risk of developing CA-AKI compared to those without hypertension. Conclusion: The likelihood of contrast-associated nephropathy appears to be markedly increased in hypertensive individuals undergoing contrast-enhanced CT in emergency departments. Prophylactic intravenous hydration has also been demonstrated to play a crucial role in reducing CA-AKI incidence.

1 January 2025 in Journal of Medical Biochemistry
Verified
Journal Article
Open access
SASali̇ha Aksun
Sali̇ha Aksun
KOKaralar Oguz
Karalar Oguz
MÜMert Üğe
Mert Üğe
BCBerna Cafer
Berna Cafer
Background: Originally classified among antiepileptic drugs, pregabalin has been prescribed for clinical conditions such as neuropathic pain, generalised anxiety disorder, and fibromyalgia. In recent years, accumulating evidence has highlighted its potential for misuse and abuse, particularly among individuals with a high prevalence of opioid dependence. This study aims to conduct a comprehensive bibliometric analysis of global research on pregabalin misuse and abuse, to identify key trends, influential contributors, and collaborative networks. Methods: Bibliometric design was employed using data retrieved from the Web of Science Core Collection database. The search was conducted in February 2025, and relevant publications were identified based on predefined inclusion and exclusion criteria. A total of 449 eligible records were exported and compiled for analysis. The bibliometric analysis was carried out using the bibliometrix R package and its Web-based interface Biblioshiny, both operating within the RStudio environment. Results: The analysis revealed a notable increase in scientific output on pregabalin misuse and dependence, particularly after 2010. The United States emerged as the most prolific and central country within the global collaboration network, followed by the United Kingdom, Germany, and France. Leading authors and institutions were concentrated in specific academic clusters. Keywords such as "abuse," "addiction," and "opioids" have shown an increasing trend since 2016. Conclusions: This study highlights the growing academic interest in the misuse and abuse potential of pregabalin, particularly over the past decade. The findings reveal a centralised research structure, with significant contributions from high-capacity countries such as the United States, the United Kingdom, and Germany. Emerging participation from developing countries, including Türkiye, underscores a broadening global awareness of the issue. The results emphasise the importance of interdisciplinary collaboration, policies, and the critical role of clinical laboratories in monitoring pregabalin-related risks.

25 March 2026 in Experimental and Clinical Endocrinology & Diabetes
Verified
Journal Article
Closed access
GEGökçe Eğlenoğlu
Gökçe Eğlenoğlu
MÜMert Üğe
Mert Üğe
IÇİsMet Çulcuoğlu
İsMet Çulcuoğlu
ŞEŞaban Esen
Şaban Esen
YÜYusuf Üzüm
Yusuf Üzüm
HYHuriye Erbak Yılmaz
Huriye Erbak Yılmaz
First-degree relatives of patients with type 2 diabetes mellitus may exhibit metabolic abnormalities and subclinical myocardial dysfunction before the onset of overt disease. Left Ventricular Speckle-tracking echocardiography (LV-STE) enables early detection of left ventricular impairment, while osteogenic biomarkers such as osteoprotegerin, osteocalcin, and osteopontin have been linked to cardiometabolic risk. This study aimed to evaluate myocardial strain parameters and serum osteogenic biomarkers in normoglycemic first-degree relatives of patients with type 2 diabetes mellitus. We enrolled 160 normoglycemic participants, comprising 80 individuals with at least one first-degree relative diagnosed with type 2 diabetes mellitus and 80 controls without such a family history. Serum osteocalcin, osteopontin, and osteoprotegerin levels were measured by ELISA. LV-STE was used to assess global longitudinal and circumferential strain from apical four-chamber (A4C), two-chamber (A2C), three-chamber (A3C), and short-axis basal/mid/apical views. Compared with the control group, the study group presented significantly lower mean short-axis basal/mid/apical and A4C/A2C/A3C strain values. The serum osteocalcin level was significantly lower and weakly negatively correlated with the fasting plasma glucose level. osteoprotegerin was positively correlated with LDL-C. No significant associations were found between strain parameters and biomarkers. Normoglycemic first-degree relatives of type 2 diabetes mellitus patients exhibit early myocardial impairment detectable by LV-STE and reduced osteocalcin levels. LV-STE may enhance early risk stratification in this population. Longitudinal studies are needed to determine the prognostic value of osteogenic biomarkers in the progression to type 2 diabetes mellitus and cardiovascular disease.

30 December 2024 in Turkish Society of Clinical Biochemistry
Verified
Journal Article
Closed access
MÜMert Üğe
Mert Üğe
SASaliha Aksun
Saliha Aksun
MEMehmet Sercan Ertürk
Mehmet Sercan Ertürk
TVTuğba Öncel Van
Tuğba Öncel Van
LDLeyla Demir
Leyla Demir
FNFigen Narin
Figen Narin
Amaç: İdiyopatik hiperandrojenemi, kadınlarda hirsutizm belirtileri, artmış serum androjen düzeyleri, normal adet döngüsü ve normal yumurtalık morfolojisi ile seyreden bir hastalık olarak tanımlanır. Bu çalışmada, Bisfenol A ve mono-etilhekzil fitalat'ın bu hastalıkla ilişkisinin incelenmesi amaçlandı. Materyal ve Metod: Araştırmaya 18-45 yaş arası toplam 91 birey dahil edildi. Hasta grubunu, endokrin polikliniğine hirsutizm bulgusu ile başvuran ve androjen düzeyi yüksek olan 43 kadın; kontrol grubunu ise hirsutizm bulgusu ve herhangi bir ek hastalığı olmayan 48 sağlıklı kadın oluşturdu. Bisfenol A ve mono-etilhekzil fitalat düzeyleri idrarda sıvı kromatografi-kütle spektrometri yöntemiyle ölçüldü. Bulgular: Hasta grubunda idrar Bisfenol A düzeyleri, kontrol grubuna göre anlamlı olarak yüksek bulundu (1,6 ng/ml; 0,55 ng/ml, p=0,035). Mono-etilhekzil fitalat düzeyleri ise kontrol grubunda, hasta grubuna göre anlamlı olarak yüksek bulundu (1,81 ng/ml; 1,66 ng/ml, p=0,01). Lojistik regresyon analizinde odds oranları, BPA için 1,91 (%95 güven aralığı: 1,13-3,24; p<0,05), yaş için 0,91 (%95 güven aralığı: 0,81-1,01; p=0,09), fT3 için 18,74 (%95 güven aralığı: 3,86-90,85; p<0,05), prolaktin için 1,06 (%95 güven aralığı: 0,98-1,14; p=0,09) olarak bulundu. Sonuç: Hiperandrojenemi etiyolojisinde daha az sıklıkla yer alan bu grupta, endokrin bozucu kimyasalların etkisinin incelenmesi çalışmamızı özgün kılmaktadır. Hasta grubunda Bisfenol A idrar düzeyinin kontrol grubuna göre yüksek olması, idiyopatik hiperandrojenemililerde Bisfenol A'nın etkisini düşündürmektedir. Kontrol grubunda ise mono-etilhekzil fitalat düzeylerinin daha yüksek bulunması, daha fazla ftalat metabolitinin incelenmesi ve daha fazla çalışma yapılması gerektiğini düşündürmektedir.